ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
IL1-M5258
製品名称
Mouse IL-13 R alpha 1 Protein, Fc Tag
タンパク質名
IL-13 R alpha 1
Species
Mouse
HOST
HEK293
200ug: 49,000円
お問い合わせ
1mg: 168,000円
お問い合わせ

Overview

Synonyms IL13RA1,CD213A1,IL-13Ra,NR4,RP13-128O4.2,IL13Rα1
Characteristics This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 62.7 kDa. The protein migrates as 67-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >95% as determined by SDS-PAGE.
Description Interleukin 13 receptor, alpha 1 is also known as IL13RA1, NR4 and CD213A1 (cluster of differentiation 213A1), The IL13 Rα1 cDNA encodes a 427 amino acid (aa) residue precursor protein with a putative 21 aa residue signal peptide, a 324 aa residue extracellular domain, a 23 aa residue transmembrane region and a 59 aa residue cytoplasmic tail. Human and mouseIL13Rα1 share 76% aa sequence identity. IL13RA1 is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4.
Reference (1) Caput, D. et al., 1996, J. Biol. Chem. 271:16921.
(2) Donaldson, D.D. et al., 1998, J. Immunol. 161:2317.
(3) Hilton, D.J. et al., 1996, Proc. Natl. Acad. Sci. USA 93:497.
URL https://www.acrobiosystems.com/P1527-Mouse-IL13RA1-ProteinC-Fc-Tag.html

お問い合わせリスト(-)

お問い合わせフォーム